Home » Topics » BioWorld Science, Respiratory

BioWorld Science, Respiratory
RSS

AnaptysBio reports interim analysis data from ECLIPSE phase II study of etokimab

Aug. 11, 2020

Bayer begins phase II study of inhaled PEGylated adrenomedullin in ARDS

Aug. 11, 2020

Boehringer Ingelheim initiates phase II study of BI-1015550 in IPF

Aug. 10, 2020

EC approves Xolair as treatment of severe chronic rhinosinusitis with nasal polyps

Aug. 7, 2020

Chinese researchers identify LPAR1 antagonists

Aug. 7, 2020

Phase I/II trial set to evaluate ARO-ENaC in cystic fibrosis

Aug. 5, 2020

Phase II study evaluates BMS-986278 in lung fibrosis

Aug. 4, 2020

NTR-441 developed to clear neutrophil extracellular traps in severe cases of COVID-19

Aug. 4, 2020

FDA clears first IND application for RLS-0071

July 29, 2020

Lung Therapeutics initiates phase II trial of LTI-01 for pleural effusion

July 27, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...